Andrei Stanciu

Andrei Stanciu is currently the Area Controller EMEA at Abbott GmbH, a role they have held since transitioning through various finance positions within the company since 2010, including Finance Director and FP&A Manager EMEA. Prior to their tenure at Abbott, they worked at Mylan as Finance Director and held the Head of Finance Oncology position at Novartis from 2017 to 2019. With a foundation in finance from Academia de Studii Economice din București, where they earned both a Bachelor's degree and a Master's degree, Andrei has continuously advanced in roles that encompass planning, reporting, and accounting supervision. Their early career included positions at Solvay and Solvay Pharma Romania, where they honed their skills in finance analysis and coordination.